Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dr. Reddy’s has strengthened its over the counter (OTC) by launching Nise D pain relief spray in India.
Subscribe to our email newsletter
The formulation for the spray includes three important ingredients which get absorbed quicker, penetrate deep to reach the source of pain and reduce inflammation.
Nise D Spray will be available in pocket pack at Rs 99/- ($1.5) and home pack for Rs 130/- ($1.9).
Dr. Reddy’s said the market for pain relief products is about Rs 1,700 crore ($259m) in India and pain relief sprays are increasing 20 times faster than creams and gels.
Dr. Reddy’s EVP and head of branded markets for India & Emerging countries M V Ramana said: "Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio.
"Nise gel has made remarkable headway into the market and looking at the market dynamics and consumer requirements, we expect Nise D Spray to have a great momentum and significant market share across regions."
Dr. Reddy’s offers a portfolio of products and services that include active pharmaceutical ingredients, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
The company’s major therapeutic areas include gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infectives. It operates in 26 countries globally.